Health-care roadblocks stymie patients: David Zitner in Troy Media
The Nova Scotia Health Authority lets an inefficient telephone system act as an important barrier to timely care, writes David Zitner. By David...
I Don’t Need a Crystal Ball to Know Your President’s Drug Importation Plan Will Flop: John Adams in Inside Sources
We Canadians urge our American friends to seek real solutions to current problems and not to embrace empty promises. The concept of cheap...
The ‘Price of Caution’ during a pandemic: MLI Commentary by David Zitner
OTTAWA, ON (August 13, 2020): The COVID-19 pandemic has exposed weaknesses in our health care systems, but to what extent remains unclear. Moreover,...
Drug prices can go too low: Richard C. Owens in the Financial Post
By determinedly reducing revenues Canada not only ensures the unavailability of existing medications, it sees to it that far fewer new ones will...
Measuring Health and Managing Health Care Routinely and in Pandemics: David Zitner for Inside Policy
In the absence of COVID testing capacity, it is important to identify the most common problems in communities and the interventions that are...
Rush to expand MAiD turns policy-making on its head: Harvey Schipper and Harry Swain in the Vancouver Sun
There is something troubling, even dangerous, about the way MAiD is evolving in Canada, and that is the absence of evidence, write Harvey...
How pandemic modelling failed policy-makers, and how to do better: MLI Commentary by Harvey Schipper
OTTAWA, ON (July 9, 2020): The existing models for epidemics, which were used to trigger lockdowns around the globe in response to COVID-19,...
The Patented Medicine Prices Review Board is selling Canadians a lemon: Nigel Rawson for Inside Policy
The federal government is pursuing an aggressive agenda using untried methods to regulate extremely low drug prices, writes Nigel Rawson. By Nigel Rawson,...
COVID-19 Highlights Weaknesses in Canada’s System for New Medicines: MLI report by Rawson and Adams
OTTAWA, ON (June 18, 2020): The COVID-19 pandemic has revealed numerous weaknesses in Canadian health care, and as the world races for new...
Don't let price controls delay access to a vaccine: Nigel Rawson and Olaf Koester in the Financial Post
Unless Ottawa guarantees the price or postpones the PMPRB revisions, manufacturers will not know whether a tendered price is compliant with the new...
